Marie Epstein

Principal Accounting Officer, Proteostasis Therapeutics (United States).

Companies

Proteostasis Therapeutics (United States)Principal Accounting Officer Dec 28, 2020 to Dec 6, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Proteostasis Therapeutics (United States)8,883 shares²Dec 2, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 2, 2022Sold 1,976 shares at $1.69 of Proteostasis Therapeutics (United States)²
Jun 3, 2022Sold 1,806 shares at $1.19 of Proteostasis Therapeutics (United States)³
Dec 1, 2021Granted 12,665 shares of Proteostasis Therapeutics (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARProteostasis Therapeutics (United States), Principal Accounting Officer
2
SEC EDGARProteostasis Therapeutics (United States) shares after the filing of Dec 2, 2022
3
SEC EDGARForm 4 filed Jun 6, 2022
4
SEC EDGARForm 4 filed Dec 3, 2021